ETF · holdings as filed 2026-05-31
What's inside GNOM?
Global X Genomics & Biotechnology ETF
- Holdings
- 51
- positions in the fund
- Top 10
- 41%
- of fund assets
- Expense ratio
- 0.50%
- net, per year
- Fund size
- $56M
- total net assets
Top 20 holdings
| Rank | Logo | Ticker / Name | Weight | |
|---|---|---|---|---|
| 1 | G  | GHGUARDANT HEALTH INC | 5.43% | |
| 2 | I  | ILMNILLUMINA INC | 4.68% | |
| 3 | N  | NTRANATERA INC | 4.03% | |
| 4 | B  | BMRNBIOMARIN PHARMACEUTICAL INC | 3.97% | |
| 5 | A  | ARWRARROWHEAD PHARMACEUTICALS IN | 3.95% | |
| 6 | L  | LEGNLEGEND BIOTECH CORP-ADR | 3.93% | |
| 7 | P  | PRAXPRAXIS PRECISION MEDICINES I | 3.89% | |
| 8 | T  | TWSTTWIST BIOSCIENCE CORP | 3.85% | |
| 9 | V  | VRTXVERTEX PHARMACEUTICALS INC | 3.84% | |
| 10 | C  | CRSPCRISPR THERAPEUTICS AG | 3.74% | |
| 11 | V  | VCYTVERACYTE INC | 3.53% | |
| 12 | Q  | QGENQIAGEN N.V. | 3.43% | |
| 13 | B  | BNTXBIONTECH SE-ADR | 3.31% | |
| 14 | T  | TECHBIO-TECHNE CORP | 3.31% | |
| 15 | M  | MRNAMODERNA INC | 3.18% | |
| 16 | T  | TXG10X GENOMICS INC-CLASS A | 3.14% | |
| 17 | B  | BEAMBEAM THERAPEUTICS INC | 3.00% | |
| 18 | ? | —BNYREPOS | 2.96% | |
| 19 | L  | LLYELI LILLY & CO | 2.25% | |
| 20 | R  | RAREULTRAGENYX PHARMACEUTICAL IN | 2.19% |
Top holdings — Health Care
Your 10 largest positions in this sector
1
G
GHGUARDANT HEALTH INC
5.43%2
I
ILMNILLUMINA INC
4.68%3
N
NTRANATERA INC
4.03%4
B
BMRNBIOMARIN PHARMACEUTICAL INC
3.97%5
A
ARWRARROWHEAD PHARMACEUTICALS IN
3.95%6
L
LEGNLEGEND BIOTECH CORP-ADR
3.93%7
P
PRAXPRAXIS PRECISION MEDICINES I
3.89%8
T
TWSTTWIST BIOSCIENCE CORP
3.85%9
V
VRTXVERTEX PHARMACEUTICALS INC
3.84%10
C
CRSPCRISPR THERAPEUTICS AG
3.74%Top holdings — United States
Your 10 largest positions in this country
1
G
GHGUARDANT HEALTH INC
5.43%2
I
ILMNILLUMINA INC
4.68%3
N
NTRANATERA INC
4.03%4
B
BMRNBIOMARIN PHARMACEUTICAL INC
3.97%5
A
ARWRARROWHEAD PHARMACEUTICALS IN
3.95%6
L
LEGNLEGEND BIOTECH CORP-ADR
3.93%7
P
PRAXPRAXIS PRECISION MEDICINES I
3.89%8
T
TWSTTWIST BIOSCIENCE CORP
3.85%9
V
VRTXVERTEX PHARMACEUTICALS INC
3.84%10
V
VCYTVERACYTE INC
3.53%Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold GNOM alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Funds similar to GNOM
Data source: official SEC Form N-PORT filings (as of 2026-05-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
Informational and educational only — not investment advice.